Company news

Standard BioTools Inc. news in 2024

Standard BioTools Inc.'s news releases, calls and decks from 2024, newest first.

View company

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 18, 2024

Standard BioTools Appoints Alex Kim as Chief Financial Officer

November 6, 2024

Standard BioTools Reports Third Quarter 2024 Financial Results

October 29, 2024

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

October 15, 2024

Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform

September 23, 2024

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

September 17, 2024

Standard BioTools Reports Second Quarter 2024 Financial Results

July 30, 2024

Standard BioTools Announces Senior Leadership Changes

July 30, 2024

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

July 16, 2024

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

May 27, 2024

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 19, 2024

Standard BioTools Reports First Quarter 2024 Financial Results

May 7, 2024

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

April 24, 2024

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

April 24, 2024

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

April 7, 2024

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

April 2, 2024

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

March 17, 2024

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

February 27, 2024

Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing

February 25, 2024

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

February 13, 2024

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

February 6, 2024

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

January 7, 2024

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

January 4, 2024

Standard BioTools Stockholders Approve Merger with SomaLogic

January 3, 2024

Calls in 2024

Decks in 2024